JNJ 40929837

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ 40929837, covering 2015-12-21 to 2015-12-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge Model [Phase 2]

See pricing